North America Narcolepsy Market
No. of Pages: 118 | Report Code: TIPRE00008100 | Category: Life Sciences
No. of Pages: 118 | Report Code: TIPRE00008100 | Category: Life Sciences
North America narcolepsy market is anticipated to reach US$ 2,024.8 Mn in 2027 from US$ 919.6 Mn in 2018. The Narcolepsy market is expected to rise with a CAGR of 9.3% from 2019-2027.
The narcolepsy market is estimated to grow due to the key driving factors such as rising sleeping disorders and growing pharmaceutical industry. However, the market is expected to face restraining factors such as no cure treatment for narcolepsy
Narcolepsy is a disorder of chronic neurological disorder; the disorder impacts the brain’s ability to control sleep and wake-up cycle. A person can get affected by the disorder in childhood, young age, or in adulthood, which from 17 years to 25 years. The most widely seen symptoms seen are excessive daytime sleepiness, cataplexy, sleep paralysis, and hallucinations. The disorder is a frequent disorder among the people across the North American region and is the second leading cause of excessive daytime sleepiness. According to the National Organization for Rare Disorder, it is stated that the incidences of narcolepsy are 1 in 2,000. Similarly, as per the National Institute of Neurological Disorders and Stroke, it is estimated that across the United States, nearly 135,000 to 200,000 people are living narcolepsy.
The rise in sleep disorders is impacting the working efficiency of people, and it is also affecting the performance of children in the studies. Similarly, it is affecting older people. The disorder increases the risk as the age grows, and it may stop breathing activity during sleep time. According to the studies published by Oxford Academics in April 2018, it is stated that the incidences are widely seen among women. The study also stated that the incidences were higher among the people between 21–30 years of age group. It is also expected that narcolepsy is caused by environmental exposures before the age of beginning in genetically inclined individuals.
It is expected that the incidences of sleep disorders are likely to grow in the coming years. Sleep disorders have become a great concern among the people of the North American region. Over 50 million people in the region are suffering from more than 80 different sleep disorders, and nearly 20 to 30 million are living with recurrent sleep disorders every year. Thus, rising sleeping disorders are likely to demand treatment for narcolepsy, which will eventually lead to the growth of the market in the coming future.
Strategic insights for the North America Narcolepsy provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 919.6 Million |
| Market Size by 2027 | US$ 2,024.8 Million |
| Global CAGR (2019 - 2027) | 9.3% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The geographic scope of the North America Narcolepsy refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
North America Narcolepsy – Market Segmentation
North America Narcolepsy Market – By Type
North America Market – By Product
North America Market – By Distribution Channel
By Geography
Company Profiles
The List of Companies - North America Narcolepsy Market
The North America Narcolepsy Market is valued at US$ 919.6 Million in 2018, it is projected to reach US$ 2,024.8 Million by 2027.
As per our report North America Narcolepsy Market, the market size is valued at US$ 919.6 Million in 2018, projecting it to reach US$ 2,024.8 Million by 2027. This translates to a CAGR of approximately 9.3% during the forecast period.
The North America Narcolepsy Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Narcolepsy Market report:
The North America Narcolepsy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Narcolepsy Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Narcolepsy Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Narcolepsy Market
